Peter Rouse

Senior Consultant Health Economics and Outcomes Research

Peter Rouse is an experienced health economist who joined MAP Biopharma in November 2019 as a Senior Consultant within the HEOR team. Peter has a background in health economic consulting, specialising in health economic modelling for early pricing of assets and HTA submissions, whilst also covering other areas of evidence generation and synthesis, including systematic literature reviews, (network) meta-analysis, preparation of global value dossier, HTA landscape analysis, local reimbursement dossier preparation, and outcomes research using patient-level data. Peter has experience leading successful HTA submissions across Europe, including NICE, SMC and AWMSG, with focus on orphan products and gene therapies for rare disease areas and oncology. Prior to consultancy, Peter worked at the National Clinical Guideline Centre (NCGC) hosted by the Royal College of Physicians, specialising in discrete event simulation modelling for service delivery guidelines, whilst also working on disease specific projects such as type 2 diabetes, palliative care and asthma diagnosis and management. Peter holds a BA in Economics and International Relations from the University of Keele and an MSc in Health Economics and Decision Modelling from the University of Sheffield.

Sign-Up For Free

Sign-up to receive up-to-date information and advice on tax developments within your industry.

Sign-up for free